FABHALTA

IPTACOPAN · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for FABHALTA, covering 2023-12-05 to 2025-12-19. Get the full timeline:

Most recent: EMA Authorised: Fabhalta (iptacopan hydrochloride monohydrate) — Novartis Europharm Limited